{"name":"iCo Therapeutics Inc.","slug":"ico-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxOZk5kZ19ZbDZ3bHhrWF90V0hCMS1sSDR4N2hwSDlqRzQ2M0ExRTBYRFZFMTc4aTNJTUFHZFItdTE4aWVfbVdVZm9lZklhanBfLXdYdUNwcExYejRETDBMNTJtanZCUHF5RUxqekRwcWhqQkRiSUEzMDNOR2V1V1RkNWd2SUVlZHB2Tmw2UDVkQTJza3RaVzFqMXlUaHBmS1RCWktCUjhzNHk3YXJiV2tkQWJxR0g0anU1dXlhWA?oc=5","date":"2026-03-18","type":"regulatory","source":"Stock Titan","summary":"FDA approves first oral IL-23 psoriasis pill, Protagonist lands $50M - Stock Titan","headline":"FDA approves first oral IL-23 psoriasis pill, Protagonist lands $50M","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNb0FHanYzeFNraDlTOHktU0xXS2dsWWNtMlFDYjR6Mk01elFnNHJ6V1lfeGhDSW5fWTMzSmlnZVZvemd2Q0VrU2I1NU9PY3FlSjRha2NKQ1FUbXBVSnZ5dUtfaURSVjQ5cU90UDlTYUdoU3dBMDhJelRwWHRaTGZuSUVXZXFrbDlGYmhOWVRYYzR6bUpLVlB5UGZUc2xIUmM3?oc=5","date":"2025-03-24","type":"pipeline","source":"Insightace Analytic","summary":"Antisense Oligonucleotide Therapeutics Market Current Scenario Analysis Report - Insightace Analytic","headline":"Antisense Oligonucleotide Therapeutics Market Current Scenario Analysis Report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQSUNFdTl2eTFIWlNCcERhS1ZGenBrVjJmSzRfN0NIbktrRHBQVl9YY01EQjAxOUdaOEFLU2FOWVpPaUF5MFFoZmk2NmVHQ0duTGphWFdqcFVqSFE1enVIalBuQlVtYjlqdU83WmhqVl9rQk5uV2NVYXB4R1VGdFBPM09GVWZ5WmM?oc=5","date":"2021-07-08","type":"regulatory","source":"Yahoo Finance","summary":"iCo Therapeutics Inc. Announces TSX Venture Exchange Conditional Approval and Provides Update Regarding Business Combination with Satellos Bioscience Inc. - Yahoo Finance","headline":"iCo Therapeutics Inc. Announces TSX Venture Exchange Conditional Approval and Provides Update Regarding Business Combina","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirAJBVV95cUxQYjI0YnJwbEl2OUdOUEhDdDFONWx5dF9BRnpDY19QYzcyT0VELXppbmRaZ0w4TkkyaWVobTJfYlpGTVc4VEQ4bWJmSFg4SHBZMFB4UUIxR0libnBpdkpkVUhKdDVnV3FIV3pTWjdzazZUSnpTbkFRd2xhajR5MlMwNGZJNWZ3bEc3R3Fpbk4xYmkybVY5YlVCMjljM3BPakd0TW1qY0Q3SjJZZl9qb3FSSFVYSmo3NXl2bDFCTmVwMTRwcWpfREhLdVlwVV9ValZPYWxlMzVmcm1yOG1WeXJQNFdFLVhMVTVwdkNHbHJuOFJBM2lURjVBQUxiX3E0OUdCVThaYzVCOFJoYi1jUUZ1NHNsREl0UE5MMXh3X0RQRG90WVlORU9USHZMcWI?oc=5","date":"2020-06-22","type":"pipeline","source":"TMX Newsfile","summary":"iCo Therapeutics Inc. Announces Oral Amphotericin B (iCo-019) Results to be Presented at Prestigious American Pharmaceutical Sciences Meeting and Discussion Updates - TMX Newsfile","headline":"iCo Therapeutics Inc. Announces Oral Amphotericin B (iCo-019) Results to be Presented at Prestigious American Pharmaceut","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxONTU3eFdMSFV0X0E3Umthd2U5anlUUTZPN080dWV1TkZRbGE5MTdFTnNVTnV6dHJrNENmUERiNjlDN0hMakRGM0oyeDB4MmR1NFVLQWNpbFR2MnRyMk9WaEM4M1RoRVlDdU5zVm4zVUtHbU9mOXM2TjQ3MzEyQ1dwS014Q3FyWUx5UldZRDB0M2Y5cVhvMTZqQ0NLY2p3bkhHbDV5UTZqb2lVSmV1M1NMOVhNckdzbHVuRWlBQmh5VXozMWc?oc=5","date":"2020-03-23","type":"pipeline","source":"News-Medical","summary":"Wasan lab develops novel oral formulation to treat systemic fungal infections - News-Medical","headline":"Wasan lab develops novel oral formulation to treat systemic fungal infections - News","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxQOVZUOV9VV0cyMHIySUdjQmxOVThURllJNFJtQUlkSGpxX0JXbjhJTDNxSHZiVkxOZl9SZTBBWnZKQW05cjRncDVfc3MwTDRYb1M3QlVweWJIVUdjZTdvUGEyNkgyQkp3czBaaThvOEhkSF9xZDZQaGdTbXpaTzB0X2xGcW9uQkF6VkctLXU2WU02TGJjQ2tSOHdpUktZYnNmQldlbXRVMEMtMTRvLUJrUFBsV3M5dEFVdmlQa0lSdW02T1FFMy1JSE1GVVExcV91?oc=5","date":"2018-04-30","type":"regulatory","source":"Investing News Network","summary":"Key Stock Catalysts in the FDA Drug Application Process - Investing News Network","headline":"Key Stock Catalysts in the FDA Drug Application Process","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQZ252Z3RtTmZyWG1qNE5TNWtacHkzd2lBLUtCQUc2cEpHS196d05aallkVERSRXhSNGttZzZ2WWFySjJNaTRMckoxbmJUR1I3S3dmWlF1bzBmRkJjTlZ5VVJJUm1KeHVaVGRVQlVvRFptTFVDTngwQ0VVOEZYci1KRkxrM2tDbDU5U3ZrYzlodnZkNm1qRVliVg?oc=5","date":"2014-02-11","type":"pipeline","source":"University of Saskatchewan","summary":"New dean of pharmacy and nutrition announced - University of Saskatchewan","headline":"New dean of pharmacy and nutrition announced","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}